Spectros Sells Patent to Philips
PORTOLA VALLEY, Calif., May 5, 2010 — Spectros Corp. announced it will sell an optical biotechnology-related patent to Koninklijke Philips Electronics N.V. The purchase price was not disclosed.
The patent concerns multispectral pulse oximetry technology developed by Spectros. Pulse oximetry is a noninvasive method allowing the monitoring of the oxygenation of a patient's hemoglobin.
Previously, Spectros, which markets advanced molecular sensing and imaging devices that shed light on ischemia and cancer, closed technology sale, license and access agreements with Li-Cor, Caliper Life Sciences, FirstScan, Merck Research, Rita Medical and Boston Scientific Corp.
For more information, visit: www.spectros.com
MORE FROM PHOTONICS MEDIA